Dr. Farkouh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
3rd Floor
New York, NY 10029Phone+1 212-241-5586
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1996 - 1998
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
- University of Western OntarioClass of 1988
Certifications & Licensure
- NY State Medical License 2009 - 2018
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM) Start of enrollment: 2004 Apr 01
- Using Big Data to Conduct Innovative Cardiovascular Clinical Trials Start of enrollment: 2019 Oct 01
- The Açaí Berry COVID-19 Anti-Inflammation Trial Start of enrollment: 2020 Aug 04
Publications & Presentations
PubMed
- Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients.Samuel Huxley, James Moriarty, Mark A Hlatky, Ryan Lennon, Kent Bailey
The Pharmacogenomics Journal. 2024-10-08 - Diabetic retinopathy screening integrated in a multidisciplinary diabetes care clinic: a pilot project.Yuliya Lytvyn, Tina Felfeli, Lisa Dubrofsky, Atit Dharia, Jason Francis Lee
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2024-06-01 - 11 citationsOutcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.Bjorn Redfors, Gregg W Stone, John H Alexander, Eric R Bates, Deepak L Bhatt
Journal of the American College of Cardiology. 2024-02-06
Journal Articles
- Moving Beyond the StentMichael Farkouh, MD, JACC: Cardiovascular Imaging
Authored Content
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
- Prevention of Heart Failure with SGLT-2 Inhibition Insights from CVD-REALMay 2018
- Prevention of Heart Failure with SGLT-2 Inhibition Insights from CVD-REALMay 2018
- Join now to see all
Press Mentions
- CTSNet Webinar: Unifying Revascularization Guidelines Across Continents and SpecialtiesJanuary 22nd, 2025
- Cedars-Sinai Taps Renowned Cardiologist as Associate Dean of Clinical TrialsJanuary 19th, 2023
- Michael E. Farkouh, MD, MSc, Named Associate Dean for Research and Clinical TrialsJanuary 17th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: